Israel Englander’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$165K 6301
2024
Q4
$165K Buy
20,000
+10,000
+100% +$80.2K ﹤0.01% 5364
2024
Q3
$76.5K Sell
10,000
-52,100
-84% -$480K ﹤0.01% 5628
2024
Q2
$643K Buy
+62,100
New +$681K ﹤0.01% 4432
2023
Q1
Sell
-16,000
Closed -$269K 6753
2022
Q4
$269K Buy
+16,000
New +$264K ﹤0.01% 5165
2015
Q4
Sell
-843,700
Closed -$11.1M 3707
2015
Q3
$11.1M Buy
+843,700
New +$13.4M 0.02% 875
2015
Q2
Sell
-20,000
Closed -$376K 3736
2015
Q1
$376K Sell
20,000
-3,400
-15% -$58.3K ﹤0.01% 2909
2014
Q4
$388K Buy
+23,400
New +$494K ﹤0.01% 3177
2014
Q2
Sell
-75,000
Closed -$2.38M 3772
2014
Q1
$2.38M Buy
+75,000
New +$2.09M 0.01% 1657

Other funds holding PTEN

Israel Englander's PTEN Position: Q2 2026 in Review

Israel Englander reduced its Patterson-UTI (PTEN) stake by 83% in Q2 2026, selling an estimated $49.1M and leaving 895,701 shares worth $8.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

Israel Englander first reported a position in PTEN in Q2 2013 and has held it in 49 quarters since. The position peaked at $135M in Q3 2014. 435 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Israel Englander held 895,701 shares of Patterson-UTI worth $8.22M as of Q2 2026.
  • Israel Englander sold 4,400,607 Patterson-UTI shares in Q2 2026, an estimated $49.1M.
  • Patterson-UTI made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2496 holding.
  • Israel Englander first reported a position in Patterson-UTI in Q2 2013 and has held it in 49 quarters since.
  • Israel Englander's Patterson-UTI position peaked at $135M in Q3 2014.
  • 435 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.